Insecticides (India) Limited (IIL), one of India’s leading crop protection and nutrition company, has announced its financial results for the quarter and full year ended March 31, 2025.

The company has posted an 84.70 per cent jump in consolidated net profit to Rs 13.89 crore for Q4 FY 25 as compared to Rs. 7.52 crore in Q4 FY24.  During the quarter, Total income rose by 31.71 per cent to Rs 358.92 crore from Rs 272.50 crore in Q4 FY25.

For the Financial Year ended March 31, 2025, Insecticides India’s net profit rose 39.13 per cent to Rs 142.01 crore, as against Rs 102.07 crore in the previous year.

IIL launched 11 new products in FY25 including patented latest technology products. In FY25, the company acquired Kaeros Research to secure supply chains, reduce costs through direct imports and to strengthens long-term sourcing capabilities.

Commenting on the results and performance, Rajesh Kumar Aggarwal, MD of Insecticides (India) Ltd. said: “We are pleased to report a robust performance of the Company, marked by strong execution and strategic discipline, resulting in a profit growth of 39% in FY25. This performance underscores the success of the strategic framework we established —centered around profitable growth, a sharper focus on premium products, and margin enhancement. The overall business environment remained favorable throughout the year. A good monsoon and healthy reservoir levels provided strong tailwinds for rural demand and agri-input consumption. Additionally, stable raw material prices and our deep farmer connect further supported steady demand across markets.

Our continued focus on premiumization yielded positive results, driving an improvement in gross margins. We consciously prioritized value over volume, reflecting our long-term strategy of sustainable, profitable growth. This disciplined approach also led to an improvement in key return metrics, with both ROCE and ROE improving consistently even in FY25, a direct outcome of better product mix and efficient capital allocation.

Looking ahead, we remain optimistic about the upcoming seasons. We expect continued momentum supported by favorable macro tailwinds such as a strong monsoon forecast and stable raw material prices. Our growth outlook remains intact, with expectations of expansion in premium products, stable gross profit margins, and EBITDA improvement, driven by new launches and operational efficiencies.

Recently we also launched Altair, a patented pre-emergent herbicide for paddy developed by Nissan Chemical Corporation, Japan, which will be exclusively marketed by us in India. This launch is a testament of our commitment to deliver innovative and effective solutions that address the real challenges faced by Indian farmers. With a robust product pipeline and planned launches in the coming year and in recent years, we are well-positioned to capture emerging opportunities in the market. While continued investment in future majorly at Dahej capacity expansion and upgraded technical and formulation facilities at Sotanala, Rajesthan.

We remain deeply committed to sustainability, innovation, and responsible growth. As we move forward, our focus stays firmly on delivering long-term value for our stakeholders, while creating a positive impact on the environment and the communities we serve. With a strong foundation and clear vision, we are confident in building a resilient, promising future for our business